FDA
approval
· 2024-12-31
FDA Approved: SUMATRIPTAN — Original Application (Rising Pharma Holdings, Inc.)
Summary
FDA approval of a generic Sumatriptan product (Original Application) by Rising Pharma Holdings, Inc. for acute treatment of migraine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SUMATRIPTAN (SUMATRIPTAN)